J neurosurg spine 25:665-670, 2016 S urgical site infections (SSIs) can be a major complication leading to worse outcomes after spinal surgery. 17 Postoperative infection can lead to repeat surgery for wound revision or removal of implanted hardware. The increasing incidence of surgical wounds infected with resistant strains of bacteria constitutes a growing problem and makes proper long-term antibiotic management difficult. 3, 5, 13 In addition to standard antiseptic surgical technique, perioperative measures including intraoperative intraveabbreviations CI = confidence interval; LV = lyophilized vancomycin; PBS = phosphate-buffered saline; SSI = surgical site infection. obJeCtive Surgical site infections (SSIs) are a major source of morbidity after spinal surgery. Several recent studies have described the finding that applying vancomycin powder to the surgical bed may reduce the incidence of SSI. However, applying vancomycin in high concentrations has been shown in vitro to inhibit osteoblast proliferation and to induce cell death. Vancomycin may have a deleterious effect on dural healing after repair of an intentional or unintentional durotomy. This study was therefore undertaken to assess the effect of different concentrations of vancomycin on a human dura mater cell culture. MethoDs Human dura intended for disposal after decompressive craniectomy was harvested. Explant primary cultures and subcultures were subsequently performed. Cells were characterized through common staining and immunohistochemistry. A growth curve was performed to assess the effect of different concentrations of vancomycin (40, 400, and 4000 μg/ml) on cell count. The effect of vancomycin on cellular shape, intercellular arrangement, and viability was also evaluated. resULts All dural tissue samples successfully developed into fusiform cells, demonstrating pseudopod projections and spindle formation. The cells demonstrated vimentin positivity and also had typical features of fibroblasts. When applied to the cultures, the highest dose of vancomycin induced generalized cell death within 24 hours. The mean (± SD) cell counts for control, 40, 400, and 4000 μg/ml were 38. 72 ± 15.93, 36.28 ± 22.87, 19.48 ± 6.53, and 4.07 ± 9.66, respectively (p < 0.0001, ANOVA). Compared with controls, vancomycin-exposed cells histologically demonstrated a smaller cytoplasm and decreased pseudopodia formation resulting in the inhibition of normal spindle intercellular arrangement. ConCLUsions When vancomycin powder is applied locally, dural cells are exposed to a concentration several times greater than when delivered systemically. In this in vitro model, vancomycin induced dural cell death, inhibited growth, and altered cellular morphology in a concentration-dependent fashion. Defining a safe vancomycin concentration that is both bactericidal and also does not inhibit normal dural healing is necessary.
nous antibiotics, 5, 11 presurgical baths, 2 and mupirocin nasal ointments 10 have been effective in reducing the incidence of SSI after spinal surgery. The topical application of lyophilized vancomycin (LV) to the surgical bed following spinal surgery can achieve very high concentrations in the surgical site with minimal systemic repercussions. 6, 18, 19 Although 3 recently published meta-analyses have described a decrease in the incidence of SSI after spine surgery with the use of topical vancomycin powder applied before closure, 1, 12, 21 the true benefit of this practice is still controversial. 20 Eder at al. 4 reported that 6 mg/cm 2 of vancomycin applied to a human-derived primary culture of osteoblasts induces massive cellular death and that 3 mg/cm 2 significantly inhibited cellular growth and migration capacity, two fundamental processes necessary to achieve healing. The effect of LV on the healing process of local tissues after surgery has not been extensively studied. Rathbone et al. 16 found that 5000 μg/ml of vancomycin diminishes the number of osteoblasts present in a culture by 50%-74%.
The effect of topical vancomycin on dural cellular growth is also poorly understood. After intentional or unintentional durotomy during spine surgery, proper dural repair and healing are essential to avoid CSF leakage, which is an independent risk factor for meningitis and worse surgical outcomes. 9, 14, 15 No study has addressed the direct effect of LV on normal dural healing. The purpose of the current investigation was to specifically assess the effect of LV at different concentrations on a human dural fibroblast culture. Such an effect may have important clinical implications in the setting of closures of both intentional and unintentional durotomy.
Methods specimen Collection
The protocol was approved by the ethics committee of the Hospital Italiano de Buenos Aires, in Buenos Aires, Argentina. Human dural specimens were harvested following decompressive craniectomies where dura was resected and intended for disposal. Informed consent was obtained in every case. Specimens were kept at 4°C in a sterile saline solution overnight and processed at the laboratory the following morning. Five different samples from 5 different patients were used. Each control sample was compared with a treated one from the same patient.
As previously described, 7, 8 specimens were divided into 2-mm fragments and cultured on 30-mm culture plates (Nunc) with 2 ml of Dulbecco modified Eagle medium supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin B (Gibco), 200 mM alpha-glutamine (Gibco), and 10% bovine fetal serum (Bioser). To obtain subcultures the tissue specimens were seeded, allowing the cells to migrate over the plate. When cell confluence was reached, the tissue specimens were removed from the plate, and the cells were subcultured for amplification. The plate was treated with a 0.25% trypsin solution (Sigma) for 3 minutes. After neutralizing the trypsin with a culture medium, cells were centrifuged at 1200 G for 10 minutes, resuspended, and plated onto T-75 flasks (Nunc). Amplified cells were quantified as per the Trypan Blue exclusion method, and 10,000 cells were seeded on 30-mm plates. All experiments for the study were performed with twice-subcultured cells.
immunohistochemistry
Cells were typified by common histological techniques and immunohistochemistry. Cells were characterized by staining with antivimentin antibodies (Millipore). The culture was fixed in 4% paraformaldehyde for 24 hours and included in paraffin. Axial slices were performed, placed onto slides, and rehydrated in the usual fashion. They were then washed with phosphate-buffered saline (PBS) pH 7.2, treated with PBS with Triton X-100 for 10 minutes, and incubated with PowerblockTM (BioGenex) for 5 minutes to block nonspecific binding sites. The primary antibody was incubated overnight at 4°C in a moist chamber. The following day, they were washed with PBS and incubated with a biotinylated secondary antibody (MultilinkTM; BioGenex) for 30 minutes at room temperature, and then with fluorescein streptavidin (Vector Labs) for 60 minutes. They were washed a final time with PBS pH 8.2. Lastly, they were mounted and analyzed under a Nikon Eclipse E400 microscope. Nuclei were stained with Hoeschl stain.
treatment with vancomycin
Vancomycin (Pfizer) was used at 3 different concentrations, chosen to reflect the variability that may be found clinically in postsurgical tissue. Although the true concentration of LV in wounds is unknown, we chose these concentrations to address the spectrum that was found in human wounds by Sweet et al. 18 Cells were constantly exposed to LV, and both the medium and the antibiotic were changed every 2 days. Each concentration was applied to 5 different plates (n = 5).
Cell Count
Cells were counted daily using a bright-field microscope (Nikon Eclipse E400). The cell count was expressed as the average of 10 fields at a magnification of 10. A control curve and a curve for each concentration of LV were performed. Photographs were taken to simplify cell counting.
analysis of Cell structure and viability
On the third day of culture, 9 treated plates were compared with control samples to assess for cell structural changes and viability. To assess for cell viability, a mixed solution containing acridine orange and ethidium bromide was added to 3 culture plates, and the cells were then observed under the florescence microscope. Because live cells are not permeable to ethidium bromide, and dead cells are permeable to both dyes, live cells appear green and dead cells appear red. The supernatant of the 3 treated cultures was analyzed with the Trypan Blue exclusion test to evaluate for unattached cells, a sign of lost viability. The hematoxylin and eosin technique was used to look for structural differences of the fibroblast cells (i.e., cell morphology) between 3 treated controls and the different samples exposed to LV.
statistical analysis
An ANOVA model for repeated measures was used. Cell count was taken as a response variable. Explanatory variables included treatment with LV at 3 different concentrations. The 6 measurements used were chronologically ordered along a 6-consecutive-day sequence. Main effects (i.e., effects of fixed factors) on the number of cells present in the culture were estimated. Differences between means were assessed with the Student t-test. Statistical analysis was performed using SPSS software (version 20, IBM). All p values < 0.0125 were considered statistically significant for ANOVA analysis (Bonferroni correction for multiple testing), and < 0.05 for other comparisons.
results
Dural samples were harvested from 5 patients during craniotomy. A cell subculture was successfully obtained from each case. All cultured cells had similar characteristics of the fibroblast dural cultures previously described by our group, including elongated elements displayed in a fusiform pattern and vimentin positivity (Figs. 1 and 2) . The Masson trichrome stain revealed morphological features typical for fibroblasts as well as collagen deposition.
Cell Count
A growth curve was performed for all 5 subcultures.
The plates (30 mm) were seeded with 10,000 dural fibroblast cells. The next day (Day 0), cells attached to the plates were counted and divided among controls or 1 of the 3 different concentrations of LV (n = 5). There were no differences in the number of cells present in the samples destined to each treatment. In the 4000 μg/ml treatment group, each plate exhibited massive cell death demonstrated by the presence of unattached cells (Fig. 3) that were confirmed as nonviable by the Trypan Blue exclusion method. Adding 40 and 400 μg/ml of LV induced a significant reduction in the number of cells present in the culture over the 5-day period (control, 38.72 ± 15.93 cells; 40 μg/ml, 36.28 ± 22.87 cells; 400 μg/ml, 19.48 ± 6.53 cells; and 4000 μg/ml, 4.07 ± 9.66; p < 0.0001, ANOVA). Although the difference was significant between the control cultures and cells treated with 40 μg/ml during the first 3 days, this difference disappeared by Day 4 (Fig. 4) .
structural Changes
On the third day after seeding, cells were analyzed for structural changes. Because no cells were alive in the cultures treated with 4000 μg/ml LV, viability and structural changes were analyzed for the 400 μg/ml treatment group only. Cells exposed to the 400 μg/ml LV concentration showed a marked reduction in pseudopodia formation and smaller cytoplasms (Fig. 5) . Also, the normal fusiform arrangement pattern characteristic of an untreated fibroblast culture was replaced by a large number of abnormal round cells, indicating cytoplasm de-arrangement. Similar find- ings were present in 3 samples both observed under the inverted microscope and after H & E staining.
Cell viability
Fewer viable cells, measured by differential uptake of ethidium bromide and acridine orange, was noted in the LV 400 μg/ml group compared with controls (n = 3). Also, a significant number of dead cells was observed on the supernatant of the treated specimens (11,600 ± 2886 cells), while all the cells in the control group remained attached to the plate in a normal and healthy fashion (Fig. 5) .
Discussion
The use of vancomycin powder to prevent SSIs after spinal surgery is controversial. In a recent meta-analysis, Bakhsheshian et al. 1 concluded that the topical application of this antibiotic had an overall protective effect against SSI (odds ratio 0.23, 95% confidence interval [CI] 0.11-0.5). However, the only randomized controlled trial included in their analysis did not show any benefit between the treatment and control groups. Furthermore, effective concentrations required to achieve the desired bactericidal effect are difficult to evaluate and have not been well established.
Although higher concentrations of LV may indeed improve its efficacy in SSI prevention, the effect of higher concentrations of this antibiotic on dural healing has never been evaluated. In the current study, LV applied in 3 different concentrations was demonstrated to induce cellular necrosis and inhibit proliferation of human dural fibroblasts. Healing after surgery involves an initial inflammatory response followed by a proliferative phase that requires viable fibroblasts to fill the defect and synthesize a new extracellular matrix. The presence of LV could therefore inhibit this process. 20 Eder et al. 4 described the effect of 3-12 mg/cm 2 of LV on a primary human-derived osteoblast culture. Similar to the present study, their model also found that LV induced cell death in a concentration-dependent manner. However, the concentrations used by these investigators were generally many times larger than the ones used in our study. Eder et al. also observed changes in cell morphology that were similar to the ones described in the current study. Their experiments included only a single examination of cells 24 hours after application of antibiotics alone, but not a growth curve. Furthermore, in that study data were collected at a single time point (status-post 24 hours) and not at multiple time points. By assessing the cell count on numerous time points, our data show that dural fibroblast cells can overcome the detrimental effect of LV at a lower dose.
In vitro experiments do not take into consideration a number of variables present in a living organism. In this case, differences between our model and the actual environment of a healing wound include blood supply and a drain that may somewhat reduce the clinical concentration of LV. Also, the vancomycin powder and the dura can be (depending on the case) separated by a muscle layer, muscular fascia, and grafts commonly placed over the dura.
One of the difficulties that arises in studying the efficacy of LV is to determine the concentration of the drug to which the tissues are exposed. Depending on institutional preferences, the doses applied to the surgical bed can vary between 0.5 and 2 g. An estimate of the concentration of LV can be obtained by sampling the drains after surgery, as shown by Sweet et al. 18 They attempted to determine this concentration by analyzing the drain output. They found a mean concentration of 1457 μg/ml (95% CI 263-2938 μg/ml) on the same day of surgery and 128 μg/ml (95% CI 37-311 μg/ml) 5 days after surgery. Because LV is applied as a precipitate, the quantity dissolved in the liquid drainage may not accurately represent the drug levels present in the tissue. The exact concentration of LV within the surgical wound may actually be quite higher than the concentration found within the surgical drain output.
The LV concentrations used in this study, representing the range that has been studied by prior investigators, severely negatively impacted the normal growing capacity of human dural fibroblasts. This inhibition of dural fibroblast proliferation might very well translate into a delay in the dural healing process after surgical closure of the dura. These LV dosages have also not been sufficiently correlated with the intended bactericidal effects in the clinical setting of spine surgery.
Future experiments will determine the effect of LV on dural healing in in vivo models, specifically evaluating the incidence of CSF leakage after durotomy repair with vancomycin powder application as well as its efficacy to prevent SSI. The goal for future studies will be to determine the specific dose of LV that is most effective in preventing SSI and at the same time does not impair normal tissue healing.
Conclusions
When vancomycin powder is applied locally, dural cells are exposed to a concentration several times greater than when delivered systemically. In this in vitro model, LV induced dural cell death, inhibited growth, and altered cellular morphology in a concentration-dependent fashion. Defining a safe LV concentration that is both bactericidal and also does not inhibit normal dural healing is necessary. 
